Why we walk….Day 4
|

Why we walk….Day 4

This week has had me digging into my own questions about Alzheimer’s research and where the funding goes for our efforts to raise money for the Alzheimer’s Association.  I read an article this morning about the development of Aducanumab (Aduhelm^TM) which is receiving accelerated approval by the FDA in the U.S. as a treatment for Alzheimer’s…